In tandem with the arrival of global leaders in Rio de Janeiro, Brazil, for the G20 Summit this weekend, the Christ the Redeemer statue will shine in teal. This Brazilian initiative aligns with global efforts spearheaded by the World Health Organization (WHO) to galvanize a universal “Day of Action for Cervical Cancer Eradication.” Across the globe, countries are spearheading initiatives aimed at enhancing human papillomavirus (HPV) vaccination and testing, launching forward-thinking health policies geared towards the unprecedented goal of cancer elimination, and fostering community awareness.
On this day four years ago, 194 nations committed to obliterating cervical cancer, prompting WHO to implement a comprehensive worldwide strategy. Since then, remarkable strides have been made: 144 countries have embraced the HPV vaccine, over 60 nations have integrated HPV testing into their screening protocols, and 83 countries now include surgical services for cervical cancer within their healthcare packages.
“I extend my gratitude to all health workers who are pivotal to this global mission,” stated Dr. Tedros Adhanom Ghebreyesus, WHO Director-General. “While progress is evident, we continue to confront substantial disparities, notably affecting women in low-income countries. Achieving equitable access for the communities in dire need hinges on decisive leadership and consistent financial commitment.”
As the campaign enters its fourth year, governments, partners, and civil society are orchestrating diverse activities and pledges, encompassing:
– Chile’s introduction of a self-collection HPV testing pilot, a segment of its healthcare reform towards universal access.
– China’s series of academic activities, health runs, and awareness lighting in over 31 cities.
– The Democratic Republic of the Congo’s 3-day forum culminating in a cervical cancer awareness march.
– Ethiopia, with Gavi’s assistance, launching a campaign aimed at HPV vaccination for over 7 million girls.
– India’s civil society groups deploying awareness initiatives and training for health professionals.
– Ireland unveiling its Action Plan to achieve cervical cancer eradication, post its 2040 target announcement last year.
– Japan lighting up over 70 landmarks under the Teal Blue Campaign, backed by the Ministry of Health.
– Nigeria’s awareness endeavors led by the First Ladies Against Cancer.
– Rwanda’s commitment to meeting the 90-70-90 targets by 2027, ahead of the WHO’s schedule.
– South Africa delivering health provider trainings across three provinces.
Furthermore, WHO introduces progressive guidance on Target Product Profiles (TPPs) for HPV screening exams. These technical parameters advocate essential standards for novel HPV tests, functional even in remote regions of low to middle-income countries, where the disease impact is highest. TPPs underscore the need for self-sample testing and tools that promote proximity HPV testing, facilitating care delivery for women.
This new guidance is aimed at fostering innovation within the HPV testing market, spotlighting high-quality, economical, and accessible solutions, significantly necessary in resource-poor settings.
In 2020, a landmark resolution by 194 nations to eliminate a cancer spurred WHO to launch the Global Strategy to eradicate cervical cancer as a public health issue. This historical call to action by the WHO Director-General back in 2018 sparked a global social movement, leading to the annual tradition uniting communities worldwide for a Day of Action to eradicate cervical cancer.